Tag Archives: LABAICS

Blood Eosinophilia-Targeted COPD Treatment: LABA-ICS vs LAMAs

December 06, 2018 Share this content: The incidence of pneumonia rose with initiation of LABA-ICS, which was similar across all eosinophil concentrations. Blood eosinophil concentrations could be used to target patients with chronic obstructive pulmonary disease (COPD) who are likely to respond to initial long-acting bronchodilator therapy. This, in turn, may help clinicians decide between… Read More »